本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TFF Pharmaceuticals

0.0650
0.0000
成交量:- -
成交額:- -
市值:28.88萬
市盈率:-0.01
高:0.0650
開:0.0650
低:0.0650
收:0.0650
52周最高:0.0650
52周最低:0.0650
股本:444.30萬
流通股本:324.24萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.7837
每股收益(LYR):-11.8508
淨資產收益率:-220.13%
總資產收益率:-106.45%
市淨率:0.09
市盈率(LYR):-0.01

資料載入中...

2025/03/06

自願退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2025/03/06

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/06

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/06

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/03/06

重要事件披露

Form 8-K - Current report
2025/02/03

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/11/20

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/20

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/15

重要事件披露

Form 8-K - Current report
2024/08/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/29

重要事件披露

Form 8-K - Current report
2024/06/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]